Press release - 05/06/2024 Investing in a fairer future: The Robert Bosch Stiftung celebrates its 60th anniversary he Robert Bosch Stiftung is celebrating its 60th anniversary in 2024. To commemorate this, the Foundation is holding an anniversary celebration today at its headquarters in Stuttgart. Among the guests are partners from the Foundation's charitable work as well as representatives from politics, business, and society, including members of the Bosch family and company.https://www.gesundheitsindustrie-bw.de/en/article/press-release/investing-fairer-future-robert-bosch-stiftung-celebrates-its-60th-anniversary
Save the date - 25/09/2024 Robotics-4-Labautomation Symposium 2024 Konstanz , Kongress/Symposium https://www.gesundheitsindustrie-bw.de/en/event/robotics-4-labautomation-symposium-2024
Press release - 31/05/2024 Toolkit makes protein design faster and more accessible The Damietta Server broadens the accessibility to protein design research and its applications in various biotechnological and biomedical fields. Researchers at the Max Planck Institute for Biology Tübingen, the University of Tübingen, and the University Hospital Tübingen have developed a web-based toolkit to accelerate and simplify protein design without needing powerful computers or extensive protein design expertise on the user’s end.https://www.gesundheitsindustrie-bw.de/en/article/press-release/toolkit-makes-protein-design-faster-and-more-accessible
Press release - 31/05/2024 Heidelberg University successful with six bids for collaborative research In the current approval round of the German Research Foundation (DFG) Heidelberg University has been successful with six applications for grants to fund major, internationally visible research consortia. The six research consortia − three of them will reach the maximum funding length of twelve years after their extension − are to receive financial resources totalling nearly 87 million euros over a period of four years.https://www.gesundheitsindustrie-bw.de/en/article/press-release/heidelberg-university-successful-six-bids-collaborative-research
Press release - 24/05/2024 Research Training Group on Cancer Surgery: German Research Foundation approves second funding period Since 2019, the Research Training Group (RTG) "Intraoperative Multisensoric Tissue Differentiation in Oncology," a collaboration between the University of Stuttgart and the University of Tübingen, has been advancing research in medical technology. With the help of new sensor methods, the researchers want to help make surgical procedures on cancer patients safer and more effective.https://www.gesundheitsindustrie-bw.de/en/article/press-release/research-training-group-cancer-surgery-german-research-foundation-approves-second-funding-period
Press release - 23/05/2024 "They heal wounds, allow bones to grow and calm inflammation" MWK funds cell therapy research into mesenchymal stromal cells with 600,000 euros The Baden-Württemberg Ministry of Science, Research and Arts (MWK) is supporting medical researchers at Ulm University with start-up funding totalling 600,000 euros. The aim is to establish an EU consortium for the broad therapeutic use of mesenchymal stromal cells. The funding is being awarded as part of the "BEGIN - Participation in major European projects and initiatives" programme.https://www.gesundheitsindustrie-bw.de/en/article/press-release/they-heal-wounds-allow-bones-grow-and-calm-inflammation-mwk-funds-cell-therapy-research-mesenchymal-stromal-cells-600000-euros
Press release - 23/05/2024 Predicting cancer risks on the basis of national health data Scientists from the German Cancer Research Center (DKFZ) and the European Bioinformatics Institute EMBL-EBI, Hinxton, UK, are using the Danish health registers to predict individual risks for 20 different types of cancer with a high degree of accuracy. The prediction model can also be transferred to other healthcare systems. https://www.gesundheitsindustrie-bw.de/en/article/press-release/predicting-cancer-risks-basis-national-health-data
Innovation in emergency medicine - 23/05/2024 CARL pushes back the boundaries of resuscitation therapy Few people survive a cardiac arrest; blood stops flowing to the brain and other vital organs and the resulting lack of oxygen causes extensive damage to the body. In response to this, researchers at the University Medical Centre Freiburg and Resuscitec GmbH have developed CARL, an innovative resuscitation system, which – in addition to the oxygen level – adjusts numerous blood parameters to individual patient requirements. This greatly improves…https://www.gesundheitsindustrie-bw.de/en/article/news/carl-pushes-back-boundaries-resuscitation-therapy
Press release - 22/05/2024 Stretched beyond the limits of the cell: the molecular biomechanics of collagen Together with colleagues from Israel and USA, HITS researcher Frauke Gräter investigates the effects of physical force on the collagen protein in two different animal model systems. Their goal is to measure the effects of mechanoradicals on the integrity of the tissue and the well-being of the organism, with impact on health and aging.https://www.gesundheitsindustrie-bw.de/en/article/press-release/stretched-beyond-limits-cell-molecular-biomechanics-collagen
Funding 4C Accelerator Tübingen Funding programme, Funded by: Medical Innovations Incubator GmbH, Ministerium für Wirtschaft, Arbeit und Tourismus BW, Startup BW & B. Braun-Stiftung, sb_search.searchresult.label.programSubmissionDate: 22/07/2024 https://www.gesundheitsindustrie-bw.de/en/database/funding/4c-accelerator-tuebingen
Funding 4C Accelerator Tübingen Funding programme, Funded by: Medical Innovations Incubator GmbH, Ministerium für Wirtschaft, Arbeit und Tourismus BW, Startup BW & B. Braun-Stiftung, sb_search.searchresult.label.programSubmissionDate: 22/07/2024 https://www.gesundheitsindustrie-bw.de/en/database/funding/4c-accelerator-tuebingen
Funding 4C Accelerator Tübingen Funding programme, Funded by: Medical Innovations Incubator GmbH, Ministerium für Wirtschaft, Arbeit und Tourismus BW, Startup BW & B. Braun-Stiftung, sb_search.searchresult.label.programSubmissionDate: 22/07/2024 https://www.bio-pro.de/en/service/funding/4c-accelerator-tuebingen
Funding EIC Transition Funding programme, Funded by: European Commission, sb_search.searchresult.label.programSubmissionDate: 18/09/2024 https://www.gesundheitsindustrie-bw.de/en/database/funding/eic-transition-1
Funding EIC Transition Funding programme, Funded by: European Commission, sb_search.searchresult.label.programSubmissionDate: 18/09/2024 https://www.bio-pro.de/en/service/funding/eic-transition-2024
Funding EIC Transition Funding programme, Funded by: European Commission, sb_search.searchresult.label.programSubmissionDate: 18/09/2024 https://www.biooekonomie-bw.de/en/databases/funding/eic-transition-1
Funding EIC Accelerator Funding programme, Funded by: European Commission, sb_search.searchresult.label.programSubmissionDate: 03/10/2024 https://www.gesundheitsindustrie-bw.de/en/database/funding/eic-accelerator
Funding EIC Accelerator Funding programme, Funded by: European Commission, sb_search.searchresult.label.programSubmissionDate: 03/10/2024 https://www.bio-pro.de/en/service/funding/eic-accelerator
Funding EIC Pathfinder Challenges Funding programme, Funded by: European Commission, sb_search.searchresult.label.programSubmissionDate: 16/10/2024 https://www.gesundheitsindustrie-bw.de/en/database/funding/eic-pathfinder-challenges
Funding EIC Pathfinder Challenges Funding programme, Funded by: European Commission, sb_search.searchresult.label.programSubmissionDate: 16/10/2024 https://www.bio-pro.de/en/service/funding/eic-pathfinder-challenges
Press release - 20/05/2024 seleon GmbH becomes part of the aesco solutions group On May 17, 2024, aesco solutions, a leading group for production and development services (CDMO) for medical device companies, and D11Z. Ventures GmbH & Co. KG (formerly Zukunftsfonds Heilbronn) announce the closing of the acquisition of seleon GmbH.https://www.gesundheitsindustrie-bw.de/en/article/press-release/seleon-gmbh-becomes-part-aesco-solutions-group
Press release - 16/05/2024 Colorectal cancer: tracking down subtypes Colorectal cancer differs from patient to patient. That is why scientists are looking for characteristic tumors markers that allow to make predictions about the likely response to certain therapies and the individual prognosis. The aim is to identify colorectal cancer subtypes so that these can then be treated in a customized manner. https://www.gesundheitsindustrie-bw.de/en/article/press-release/colorectal-cancer-tracking-down-subtypes
Press release - 15/05/2024 Tumour tissue on a chip: new possibilities for cell therapies and personalized medicine How do tumors react to a certain therapeutic approach? Knowing this before the start of a therapy would be of enormous value for people suffering from cancer as well as for the doctors treating them. Researchers have now made this very observation possible for the CAR-T cell therapy. This allows us to individually investigate how exactly these tumor cells react to the planned therapy.https://www.gesundheitsindustrie-bw.de/en/article/press-release/tumour-tissue-chip-new-possibilities-cell-therapies-and-personalized-medicine
App for tuberculosis diagnosis - 15/05/2024 "Find-TB" aims to improve access to tuberculosis diagnostics Globally, the majority of children with tuberculosis remain undiagnosed and therefore untreated because their symptoms are categorised incorrectly. Researchers at Heidelberg University Hospital want to develop an app that analyses medical information, risk factors and local surveillance data to calculate individual risk of infection and test those who might be affected with TB as early as possible.https://www.gesundheitsindustrie-bw.de/en/article/news/find-tb-aims-improve-access-tuberculosis-diagnostics
Press release - 13/05/2024 Detecting respiratory infections: simply blow for diagnosis Professor Claudia Denkinger from Heidelberg University's Faculty of Medicine is leading the international collaborative project "BreathForDiagnosis". Researchers from Germany, Italy, South Africa and Romania are working with an industrial partner from Switzerland to develop user-friendly breath tests for the rapid diagnosis of respiratory infections such as tuberculosis.https://www.gesundheitsindustrie-bw.de/en/article/press-release/detecting-respiratory-infections-simply-blow-diagnosis
Press release - 07/05/2024 Intermittent fasting protects against liver inflammation and liver cancer / Drug partially mimics fasting effects Fatty liver disease often leads to chronic liver inflammation and can even result in liver cancer. Scientists from the German Cancer Research Center (DKFZ) and the University of Tuebingen have now shown in mice that intermittent fasting can halt this development. https://www.gesundheitsindustrie-bw.de/en/article/press-release/intermittent-fasting-protects-against-liver-inflammation-and-liver-cancer-drug-partially-mimics-fasting-effects